Wrap Text
Dealings in securities by directors, a prescribed officer of the Company and directors of major subsidiaries
DISCOVERY LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 1999/007789/06)
Legal Entity Identifier: 378900245A26169C8132
JSE share code: DSY, DSYBP
DSY ISIN: ZAE000022331
DSBP ISIN: ZAE000158564
Bond company code: DSYI
("Discovery" or the "Company")
Dealings in securities by directors, a prescribed officer of the Company and directors
of major subsidiaries
In compliance with paragraphs 3.63 to 3.74 and paragraphs 6.42 to 6.53 of the JSE Limited
("JSE") Listings and Debt Listings Requirement, shareholders and noteholders are advised
of the following information relating to the dealing in securities by directors, a prescribed
officer of the Company and directors of major subsidiaries.
The vesting and sale transactions, where applicable, occurred in terms of various long-term
employee share incentive plans. All sale transactions occurred on market following vesting
and all deliveries of awards occurred off-market.
Name of director: Mr Adrian Gore
Company: Discovery Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary Shares
Nature of transaction: Automatic vesting and sale of 63,832 shares.
Vesting price per security: R172.08
Value of vesting transaction: R10,984,210.56
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R10,959,316.08
Nature and extent of director's interest: Direct beneficial
Name of director: Mr Barry Swartzberg
Company: Discovery Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary Shares
Nature of transaction: Automatic vesting and sale of 19,036 shares.
Vesting price per security: R172.08
Value of vesting transaction: R3,275,714.88
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R3,268,290.84
Nature and extent of director's interest: Direct beneficial
Name of director: Mr Deon Marius Viljoen
Company: Discovery Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and exercise of 40,946
shares. After settling the income tax due,
through the sale of 20,474 Discovery ordinary
shares, this resulted in the delivery of 20,472
Discovery ordinary shares.
Vesting price per security: R172.08
Value of vesting transaction: R7,045,987.68
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R3,515,181.06
Nature and extent of directors interest: Direct beneficial
Name of prescribed officer: Mr Hylton Kallner
Company: Discovery Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and sale of 96,031 shares.
Vesting price per security: R172.08
Value of vesting transaction: R16,525,014.48
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R16,487,562.39
Nature and extent of directors interest: Direct beneficial
Name of director: Dr Ayanda Ntsaluba
Major subsidiary company: Discovery Health Proprietary Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and sale of 51,329 shares.
Vesting price per security: R172.08
Value of vesting transaction: R8,832,694.32
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R8,812,676.01
Nature and extent of directors interest: Direct beneficial
Name of director: Mr Fareed Chothia
Major subsidiary company: Discovery Health Proprietary Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and exercise of 20,111
shares. After settling the income tax due,
through the sale of 10,057 Discovery ordinary
shares, this resulted in the delivery of 10,054
Discovery ordinary shares.
Vesting price per security: R172.08
Value of vesting transaction: R3,460,700.88
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R1,726,686.33
Nature and extent of directors interest: Direct beneficial
Name of director: Dr Jonathan Broomberg
Major subsidiary company: Discovery Health Proprietary Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and sale of 23,311 shares.
Vesting price per security: R172.08
Value of vesting transaction: R4,011,356.88
Date of Sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R4,002,265.59
Nature and extent of directors interest: Direct beneficial
Name of director: Mr Kenneth Steven Rabson
Major subsidiary company: Discovery Life Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and sale of 42,871 shares.
Vesting price per security: R172.08
Value of vesting transaction: R7,377,241.68
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R7,360,521.99
Nature and extent of directors interest: Direct beneficial
Name of director: Ms Nonkululeko Pitje
Major subsidiary company: Discovery Health Proprietary Limited and
Discovery Life Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and exercise of 26,977
shares. After settling the income tax due,
through the sale of 13,490 Discovery ordinary
shares, this resulted in the delivery of 13,487
Discovery ordinary shares.
Vesting price per security: R172.08
Value of vesting transaction: R4,642,202.16
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R2,316,098.10
Nature and extent of directors interest: Direct beneficial
Name of director: Mr Riaan Johannes Van Reenen
Major subsidiary company: Discovery Life Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary Shares
Nature of transaction: Automatic vesting and sale of 37,846 shares.
Vesting price per security: R172.08
Value of vesting transaction: R6,512,539.68
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R6,497,779.74
Nature and extent of directors interest: Direct beneficial
Name of director: Dr Ronald Michael Whelan
Major subsidiary company: Discovery Health Proprietary Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and exercise of 35,527
shares. After settling the income tax due,
through the sale of 17,765 Discovery ordinary
shares, this resulted in the delivery of 17,762
Discovery ordinary shares.
Vesting price per security: R172.08
Value of vesting transaction: R6,113,486.16
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R3,050,072.85
Nature and extent of directors interest: Direct beneficial
Name of director: Mr Stuart Alexander Cohen
Major subsidiary company: Discovery Life Limited
Date of vesting: 30 September 2024
Class of securities: Ordinary shares
Nature of transaction: Automatic vesting and sale of 21,093 shares.
Vesting price per security: R172.08
Value of vesting transaction: R3,629,683.44
Date of sale: 30 September to 1 October 2024
Volume weighted average sale price per R171.69
security*:
Value of sale transaction: R3,621,457.17
Nature and extent of directors interest: Direct beneficial
* The highest and lowest prices traded in respect of the sale of the Discovery shares over
the respective dates of sale were as follows:
Dates Highest price traded per share Lowest price traded per share
30 September 2024 R172.49 R171.80
1 October 2024 R173.08 R170.41
The necessary clearances have been obtained.
4 October 2024
Sandton
Equity and Debt Sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)
Date: 04-10-2024 03:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
